JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Tebotelimab is a bispecific humanized monoclonal antibody which targets human Lymphocyte activation gene 3 protein and Programmed cell death protein 1.